Studies in a humanized mouse model of RA using DR1- Type II Collagen (CII) CAR T cells showed that they effectively identified and lyse CII-specific CD4+ T cells and reduced the autoimmune T cell response and the severity of RA in vivo. The gene discussed is DR1; the disease is rheumatoid arthritis.